GT Biopharma, Inc. (GTBP) Tops Q1 EPS by 16c

GT Biopharma, Inc. (NASDAQ: GTBP) reported Q1 EPS of ($0.01), $0.16 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on GT Biopharma, Inc. (GTBP) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ennis (EBF) Reports In-Line Q1 EPS
• AeroVironment restates quarterly financials, citing $89M goodwill error